Ten Trials: Chamomile Extract vs Isolated Apigenin for European Buyers

Chamomile, which contains the flavonoid apigenin, can modestly improve subjective sleep quality and ease mild anxiety for some people. Most of the supporting human data comes from chamomile extract or tea trials rather than from isolated apigenin, and a 2024 meta-analysis of ten clinical trials found a measurable but modest improvement in sleep quality scores.

TL;DR:

• Chamomile extract standardised to about 1% apigenin, typically around 4 to 6 mg per 540 mg capsule, is used in sleep trials, but tea varies widely in dose.
• Most human trials show modest improvements in sleep quality, particularly in reducing night awakenings, with effects difficult to replicate from home-brewed tea.
• Apigenin’s calming effects are largely based on laboratory evidence of GABA receptor interaction, but human confirmation remains limited.
• Adverse events from chamomile are generally mild, with careful attention needed for interactions with sleep medications, blood thinners, and allergies to related plants.
• When choosing supplements, verify specific apigenin content, third-party testing, and doses aligning with research ranges rather than vague extracts.

Table of Contents

• What is apigenin in chamomile and how much is there?
• How apigenin is thought to work for relaxation and ageing
• Human evidence: clinical trials and the 2024 meta-analysis
• Dosing, formulations and how to read labels
• Safety, interactions and who should avoid apigenin or chamomile
• How to choose a chamomile or apigenin supplement
• Why trust this guide: our approach to the evidence
• How to think about apigenin in a wellbeing routine
• Finding the right Vivetus product for your goals
• FAQ
• Sources

What is apigenin in chamomile and how much is there?

Apigenin is a flavone, a type of plant flavonoid, found in notable amounts in chamomile flowers (Matricaria chamomilla). In the plant, it rarely exists in its free form. Instead, it mostly occurs as apigenin-7-O-glucoside, a glycoside version where a sugar molecule attaches to the apigenin backbone. This matters for anyone trying to work out how much active compound they are consuming.

Glycosides are generally more water-soluble than the free form, known as the aglycone, which affects how the body absorbs and processes the compound. A review on glycoside prevalence notes that glycoside forms dominate in many botanical sources and that this chemical form can influence absorption compared with the aglycone. During digestion, enzymes in the gut typically need to cleave the sugar group before the aglycone form becomes available for absorption, a step that adds variability between individuals.

Quantifying apigenin content precisely is harder than it sounds, because yields depend on several factors:

• Plant part used: the floral heads (particularly the ligulate florets) generally carry higher flavonoid concentrations than stems or leaves.
• Cultivar and growing conditions: different chamomile varieties and growing regions produce different flavonoid profiles.
• Extraction method: solvent choice and water ratio change how much apigenin ends up in a finished extract, as described in patent documentation on extraction methods.
• Processing and drying: heat and storage conditions can degrade flavonoid content over time.

Clinical-grade chamomile extracts used in research are often standardised to roughly 1% apigenin by mass, typically somewhere between 0.8% and 1.2%, according to a 2024 review on apigenin and sleep. That means a 540 mg extract capsule might contain somewhere in the region of 4 to 6 mg of actual apigenin, depending on the batch and standardisation method. A standard cup of chamomile tea, by contrast, delivers a much less predictable and generally lower dose, since brewing conditions, flower quality and steeping time all vary between a home kitchen and a controlled extraction process. Some concentrated extracts described in extraction patents report flavone content as high as 80 to 170 mg% in the finished material, though these figures depend heavily on the specific extraction protocol used.

How apigenin is thought to work for relaxation and ageing

Apigenin’s reputation as a calming compound rests on a handful of plausible biological mechanisms, most of which have been studied in laboratory and animal models rather than confirmed in large human trials.

The most frequently cited mechanism is GABAergic modulation. Gamma-aminobutyric acid, or GABA, is the brain’s primary inhibitory neurotransmitter, and compounds that enhance its activity tend to produce calming or sedative effects. Preclinical studies summarised in the 2024 review on apigenin and ageing point to apigenin interacting with GABA receptors in animal models, offering a biological explanation for chamomile’s traditional use as a mild relaxant. Our own explainer on apigenin and GABA covers this mechanism in more detail for readers who want the fuller picture.

Beyond sedation, apigenin shows anti-inflammatory and spasmolytic (muscle-relaxing) activity in laboratory settings. These figures describe laboratory pharmacology, not a human dose: they help explain why the compound is biologically active, but they say nothing about how much a person would need to consume to feel an effect.

A newer line of research examines apigenin’s role in cellular ageing through CD38 inhibition and NAD+ modulation. CD38 is an enzyme that consumes NAD+, a molecule cells need for energy metabolism and repair processes that tend to decline with age. Animal studies referenced in the same 2024 review suggest apigenin can inhibit CD38 activity and support NAD+ levels, which has generated interest in apigenin as part of a broader healthy-ageing strategy. It is worth being direct about the gap here: this evidence comes from animal and cellular models, and human clinical confirmation of the same effect is still limited.

Dietary apigenin intake correlates with self-reported sleep quality in large observational cohorts, though this association does not establish that apigenin causes the improvement, since diet, lifestyle and other nutrients all move together in population data.

Chamomile is not a single-compound plant. It also contains chamazulene and bisabolol, two other constituents with their own anti-inflammatory and calming properties, and researchers increasingly suspect these compounds act together rather than apigenin working in isolation. This synergy question is one reason chamomile extract trials cannot be read as pure apigenin trials.

Human evidence: clinical trials and the 2024 meta-analysis

The strongest human evidence available comes from a 2024 systematic review and meta-analysis that pooled ten clinical trials covering 772 participants. The headline result: chamomile extract produced a mean reduction of 1.88 points on the Pittsburgh Sleep Quality Index (PSQI), a widely used sleep questionnaire, with a 95% confidence interval spanning -3.46 to -0.31. A lower PSQI score indicates better perceived sleep quality, so this represents a modest but statistically meaningful improvement across the pooled trials.

What stands out in the detail is which aspect of sleep improved most consistently. The analysis found the clearest benefit for nightly awakenings, meaning participants reported waking up less often during the night, rather than for total sleep duration or sleep efficiency. That distinction matters for anyone expecting chamomile to act like a classic sedative that extends total sleep time.

The individual trials feeding into this pooled result used a range of formulations and doses:

• A typical daily extract trial examined general sleep quality outcomes in adults with sleep complaints.
• Several trials used twice-daily regimens, splitting the dose across morning and evening.
• Anxiety-focused trials used higher daily doses, reflecting the different dose ranges used for anxiety outcomes versus sleep outcomes.
• A postnatal tea study examined chamomile tea specifically in new mothers, using a whole-plant preparation rather than a standardised extract.

Improvements were most consistent for nightly awakenings rather than for total sleep duration or sleep efficiency, and the pooled effect size was modest.

This pattern of findings, drawn from the 2024 meta-analysis, is a fair summary of where the evidence currently stands.

Several factors explain why the trials do not all point in the same direction with the same strength. Extracts varied in their standardisation, meaning one trial’s “540 mg extract” is not chemically identical to another trial’s “540 mg extract” from a different manufacturer. Most outcome measures relied on subjective questionnaires rather than objective tools like polysomnography, which records brain activity, eye movement and other physiological markers during sleep. Trial sizes were generally small, and treatment durations ranged from a few weeks to a couple of months, making it hard to say anything definitive about longer-term use.

The practical takeaway is measured rather than dramatic. Modest subjective improvements in sleep quality appear plausible for some people, particularly around reducing nighttime awakenings, but the evidence for improving objective measures like total sleep time or sleep efficiency remains inconsistent. Readers who want a deeper look at how chamomile extract evidence differs from claims made about isolated apigenin can see our full breakdown of the distinction.

Dosing, formulations and how to read labels

Translating clinical trial doses into a shopping decision requires understanding what is actually inside a bottle. Trials have used a range of daily amounts:

1. 270 mg, taken twice daily (540 mg total), a common regimen in sleep-focused trials.
2. 540 mg once daily, used in some general sleep quality studies.
3. Up to 1,500 mg daily, reserved for anxiety-focused trials rather than sleep studies.

One trial formulation analysed by HPLC found that 90 mg of a specific chamomile extract contained 3.9 mg of apigenin alongside 1.8 mg of (-)-alpha-bisabolol, illustrating just how much the ratio can differ between products.

Extract ratios, often written as something like “6:1”, describe how much raw plant material was concentrated to produce one unit of extract. A label stating “standardised to X mg apigenin” is more useful than a ratio alone, because it tells you the actual active compound content rather than just the concentration process. Bioavailability also depends on form: glycoside-rich preparations may behave differently in the body than aglycone-dominant extracts, which is one reason identical-sounding doses can produce different experiences between products.

Timing deserves a mention too. Most sleep-focused trials administered chamomile in the evening, generally in the hour or so before bedtime, which lines up with traditional use patterns.

Pro Tip: Check whether a product label states the apigenin content directly in milligrams rather than only listing the total extract weight, since the apigenin percentage can otherwise be impossible to work out.

When comparing products, a short checklist helps cut through marketing language: look for a stated extract ratio, a specific apigenin milligram figure rather than a vague “chamomile extract” entry, and a dose that falls within the ranges actually used in trials rather than well below or far above them. Our guide to apigenin’s broader science and ageing relevance goes into more depth on formulation choices for readers planning longer-term use.

Safety, interactions and who should avoid apigenin or chamomile

Across the clinical trials reviewed in the research, adverse events were generally mild and infrequent. Reported issues mostly involved minor digestive discomfort, with rare allergic reactions noted in some participants, typically people with existing sensitivities to plants in the daisy family, which includes chamomile.

A few interaction categories are worth being aware of before combining chamomile or apigenin with other substances:

• Sedatives and sleep medications: combining chamomile with other calming compounds may amplify drowsiness beyond what either produces alone.
• Anticoagulants and antiplatelet medications: chamomile has traditionally been flagged alongside blood-thinning drugs, warranting a conversation with a healthcare provider before combining them.
• CYP enzyme metabolism: some flavonoids can influence liver enzymes that process other medications, which is a general pharmacological consideration rather than a confirmed clinical risk for every chamomile product.

Certain groups should check with a clinician before adding chamomile or apigenin to their routine: people who are pregnant or breastfeeding, anyone currently taking prescription sedatives or blood-thinning medication, and individuals with a known severe allergy to ragweed, chrysanthemums or related plants. Our overview of sleep supplement safety covers these precautions in more detail for readers weighing up different sleep support options.

One honest gap remains in the evidence: long-term daily use of isolated, high-dose apigenin (as opposed to whole chamomile extract) has not been studied extensively in humans, so caution and moderation make sense until more data accumulates.

How to choose a chamomile or apigenin supplement

Shopping for a chamomile or apigenin product becomes far easier once you know which label details actually matter. A few checks separate a product that mirrors trial conditions from one that does not:

• Stated apigenin content: look for a specific milligram figure, not just “chamomile extract” with no breakdown.
• Third-party testing: purity, heavy metal and microbiology reports give some assurance about what is actually in the capsule.
• Clear extract ratio and botanical source: a named ratio (such as 6:1) and a clearly identified Matricaria chamomilla source are better than vague sourcing language.
• Dosing aligned with research: products offering doses far outside the 270 mg to 1,500 mg range used in trials deserve a closer look before buying.

A standardised extract generally makes more sense than tea when consistency matters, since tea’s apigenin content shifts with brewing time, water temperature and flower quality, while a standardised capsule delivers a more predictable amount serving to serving.

Avoid products marketed under vague “proprietary blend” language that hides the actual apigenin milligram content, since this makes it impossible to compare value or to judge whether the dose resembles anything used in research. A simple question to ask customer support or check on a product page: “How many milligrams of apigenin does one serving actually contain?” If a brand cannot answer that plainly, that is a useful signal in itself.

Why trust this guide: our approach to the evidence

We prioritise peer-reviewed human trials and systematic reviews over marketing claims when summarising what chamomile and apigenin can plausibly do, drawing on sources including the 2024 PSQI meta-analysis and the 2024 review on apigenin and ageing rather than extrapolating from cell or animal studies alone.

As a supplement retailer focused on healthy ageing, we assemble our apigenin and related longevity formulations in the Netherlands and publish ingredient details on our apigenin product collection, where shoppers can review formulation specifics directly. We take a vegan, GMO-free approach across our product range and aim for transparent labelling rather than vague blend descriptions.

For readers who want to go further into the cellular ageing angle, our piece on cortisol findings in cell studies versus human evidence is a useful companion to this guide, since it draws the same line between laboratory findings and confirmed human outcomes that we have tried to maintain throughout this article.

How to think about apigenin in a wellbeing routine

If you are considering chamomile or apigenin for sleep or relaxation, a short, measured trial makes more sense than an open-ended commitment. Try it for four to eight weeks, track your subjective sleep quality using something as simple as a nightly one-to-ten rating, and judge the result honestly rather than assuming it is working.

Supplements are not a substitute for sleep hygiene basics: a consistent bedtime, reduced screen exposure in the evening and a cool, dark room all tend to matter more than any single plant compound. Chamomile or apigenin work best as a small addition to those habits, not a replacement for them.

If sleep problems persist beyond a couple of months, or anxiety symptoms feel more than mild, that is a signal to speak with a healthcare professional rather than increasing the dose. Supplements have a place in a wellbeing routine, but persistent sleep disruption deserves proper attention.

— Jord

Finding the right Vivetus product for your goals

We built our product range around the same evidence base this guide has walked through, so the apigenin content on our labels reflects what research actually measured rather than a rounded-up marketing number.

For readers specifically interested in apigenin’s calming and anti-inflammatory properties, our Vivetus® Apigenin collection states its formulation clearly on the product page, making it straightforward to compare against the trial doses covered above. Beyond single-ingredient options, we also offer combination approaches for readers thinking about healthy ageing more broadly:

• The 🛡 CelBescherming bundel combines several ingredients aimed at cellular protection, suited to readers wanting a broader defensive approach rather than a single compound.
• The 🔬 Vitaal Basis bundel offers a foundational longevity stack, a reasonable starting point for readers new to this category who want core support without assembling several products individually.
• Vivetus® NMN (60 x 500 mg capsules) focuses specifically on NAD+ support, suited to readers whose main interest is cellular energy metabolism rather than sleep or relaxation.
• The ♻ CelReset bundel targets a broader cellular renewal approach, fitting readers looking for a more comprehensive routine rather than a single-ingredient focus.

Each product page lists full ingredient details, and our site supports subscription ordering for anyone who prefers not to reorder manually each month. Our customer service team is available for questions about formulation or dosing before you buy.

FAQ

Who shouldn’t take apigenin?

People who are pregnant or breastfeeding, anyone taking prescription sedatives or blood-thinning medication, and those with a known allergy to ragweed or related daisy-family plants should check with a healthcare provider before taking apigenin or chamomile. These groups face the main interaction and allergy risks noted in clinical research.

Does apigenin really work for sleep?

Human evidence largely comes from chamomile extract rather than isolated apigenin, and a 2024 meta-analysis of ten trials found a modest PSQI score improvement of 1.88 points, with the clearest benefit for reducing nightly awakenings. Effects on total sleep time and efficiency were less consistent across trials.

Is it safe to take apigenin every day?

Short-term use of chamomile extract has shown a generally mild safety profile in clinical trials, with adverse events typically limited to mild digestive discomfort or rare allergic reactions. Long-term daily use of isolated, high-dose apigenin has not been studied extensively, so moderation and periodic breaks are sensible.

What does apigenin do for your body?

Apigenin is thought to interact with GABA receptors in a way that may support relaxation, alongside anti-inflammatory and mild muscle-relaxing effects observed in laboratory studies. Animal research also points to a role in NAD+ metabolism relevant to cellular ageing, though this effect has not been confirmed to the same extent in humans.

Recommended

• Why Chamomile Trials (500 mg) Are Human Proof of Apigenin and GABA
• Apigenin and Sleep: Chamomile Data, Not Proof for Isolated Apigenin
• Apigenin: Science, Benefits, and a Guide to Healthy Aging